NCT03788083View on ClinicalTrials.gov

Intratumoral TriMix Injections in Early Breast Cancer Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 12, 2018

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2024

Conditions
Breast Cancer FemaleEarly-stage Breast Cancer
Interventions
DRUG

Trimix

Intratumoral TriMix injection

DRUG

Placebo

Intratumoral placebo injection

Trial Locations (1)

1090

RECRUITING

UZ Brussel, Jette

Sponsors

Collaborators (1)

eTheRNA immunotherapies
All Listed Sponsors
collaborator

eTheRNA immunotherapies

INDUSTRY

lead

Universitair Ziekenhuis Brussel

OTHER